The K1 capsular polysaccharide from Acinetobacter baumannii is a potential therapeutic target via passive immunization.

MLA

Russo, Thomas A., et al. “The K1 Capsular Polysaccharide from Acinetobacter Baumannii Is a Potential Therapeutic Target via Passive Immunization.” Infection and Immunity, vol. 81, no. 3, Mar. 2013, pp. 915–22. EBSCOhost, https://doi.org/10.1128/IAI.01184-12.

APA

Russo, T. A., Beanan, J. M., Olson, R., MacDonald, U., Cox, A. D., St Michael, F., Vinogradov, E. V., Spellberg, B., Luke-Marshall, N. R., & Campagnari, A. A. (2013). The K1 capsular polysaccharide from Acinetobacter baumannii is a potential therapeutic target via passive immunization. Infection and Immunity, 81(3), 915–922. https://doi.org/10.1128/IAI.01184-12

Chicago

Russo, Thomas A, Janet M Beanan, Ruth Olson, Ulrike MacDonald, Andrew D Cox, Frank St Michael, Evgeny V Vinogradov, Brad Spellberg, Nicole R Luke-Marshall, and Anthony A Campagnari. 2013. “The K1 Capsular Polysaccharide from Acinetobacter Baumannii Is a Potential Therapeutic Target via Passive Immunization.” Infection and Immunity 81 (3): 915–22. doi:10.1128/IAI.01184-12.